These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 25793498)

  • 1. Triclabendazole sulfoxide causes stage-dependent embryolethality in zebrafish and mouse in vitro.
    Boix N; Teixido E; Vila-Cejudo M; Ortiz P; Ibáñez E; Llobet JM; Barenys M
    PLoS One; 2015; 10(3):e0121308. PubMed ID: 25793498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative potency of albendazole and its sulfoxide metabolite in two in vitro tests for developmental toxicity: the rat whole embryo culture and the mouse embryonic stem cell test.
    Eckardt K; Kaltenhäuser J; Kilb C; Seiler A; Stahlmann R
    Reprod Toxicol; 2012 Nov; 34(3):378-84. PubMed ID: 22652462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triclabendazole for the treatment of fascioliasis and paragonimiasis.
    Keiser J; Engels D; Büscher G; Utzinger J
    Expert Opin Investig Drugs; 2005 Dec; 14(12):1513-26. PubMed ID: 16307491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The comparative metabolism of triclabendazole sulphoxide by triclabendazole-susceptible and triclabendazole-resistant Fasciola hepatica.
    Robinson MW; Lawson J; Trudgett A; Hoey EM; Fairweather I
    Parasitol Res; 2004 Feb; 92(3):205-10. PubMed ID: 14652740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developmental toxicity of methanol in whole embryo culture: a comparative study with mouse and rat embryos.
    Andrews JE; Ebron-McCoy M; Logsdon TR; Mole LM; Kavlock RJ; Rogers JM
    Toxicology; 1993 Aug; 81(3):205-15. PubMed ID: 8212026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response of two isolates of Fasciola hepatica to treatment with triclabendazole in vivo and in vitro.
    Walker SM; McKinstry B; Boray JC; Brennan GP; Trudgett A; Hoey EM; Fletcher H; Fairweather I
    Parasitol Res; 2004 Dec; 94(6):427-38. PubMed ID: 15517388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Albendazole causes stage-dependent developmental toxicity and is deactivated by a mammalian metabolization system in a modified zebrafish embryotoxicity test.
    Mattsson A; Ullerås E; Patring J; Oskarsson A
    Reprod Toxicol; 2012 Aug; 34(1):31-42. PubMed ID: 22414603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developmental toxicity of bromohydroquinone (BHQ) and BHQ-glutathione conjugates in vivo and in whole embryo culture.
    Andrews JE; Rogers JM; Ebron-McCoy M; Logsdon TR; Monks TJ; Lau SS
    Toxicol Appl Pharmacol; 1993 May; 120(1):1-7. PubMed ID: 8099763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fungus-benzimidazole interactions: a prerequisite to deploying egg-parasitic fungi Paecilomyces lilacinus and Verticillium chlamydosporium as biocontrol agents against fascioliasis and amphistomiasis in ruminant livestock.
    Singh RK; Sanyal PK; Patel NK; Sarkar AK; Santra AK; Pal S; Mandal SC
    J Helminthol; 2010 Jun; 84(2):123-31. PubMed ID: 19698195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fasciola gigantica: tegumental surface alterations following treatment in vitro with the sulphoxide metabolite of triclabendazole.
    Meaney M; Fairweather I; Brennan GP; Ramasamy P; Subramanian PB
    Parasitol Res; 2002 Apr; 88(4):315-25. PubMed ID: 11999018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developmental toxicity of albendazole and its three main metabolites in zebrafish embryos.
    Carlsson G; Patring J; Ullerås E; Oskarsson A
    Reprod Toxicol; 2011 Jul; 32(1):129-37. PubMed ID: 21683134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isothermal microcalorimetry to study the activity of triclabendazole and its metabolites on juvenile and adult Fasciola hepatica.
    Keiser J; Manneck T; Kirchhofer C; Braissant O
    Exp Parasitol; 2013 Mar; 133(3):265-8. PubMed ID: 23206957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triclabendazole and its two main metabolites lack activity against Schistosoma mansoni in the mouse model.
    Keiser J; El Ela NA; El Komy E; El Lakkany N; Diab T; Chollet J; Utzinger J; Barakat R
    Am J Trop Med Hyg; 2006 Aug; 75(2):287-91. PubMed ID: 16896134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of albendazole and triclabendazole on colchicine binding in the liver fluke Fasciola hepatica.
    Fetterer RH
    J Vet Pharmacol Ther; 1986 Mar; 9(1):49-54. PubMed ID: 3701915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicity of 15 veterinary pharmaceuticals in zebrafish (Danio rerio) embryos.
    Carlsson G; Patring J; Kreuger J; Norrgren L; Oskarsson A
    Aquat Toxicol; 2013 Jan; 126():30-41. PubMed ID: 23142600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative assessment of the access of albendazole, fenbendazole and triclabendazole to Fasciola hepatica: effect of bile in the incubation medium.
    Alvarez LI; Mottier ML; Lanusse CE
    Parasitology; 2004 Jan; 128(Pt 1):73-81. PubMed ID: 15002906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in preimplantation in vivo development after preconceptional chronic moderate alcohol consumption in female mice.
    Cebral E; Lasserre A; Rettori V; de Gimeno MA
    Alcohol Alcohol; 2000; 35(4):336-43. PubMed ID: 10905997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the P-glycoprotein inhibitor, R(+)-verapamil on the drug susceptibility of a triclabendazole-resistant isolate of Fasciola hepatica.
    Savage J; Meaney M; Brennan GP; Hoey E; Trudgett A; Fairweather I
    Vet Parasitol; 2013 Jul; 195(1-2):72-86. PubMed ID: 23597772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of DNA damage and embryotoxicity induced by 4-hydroperoxydechlorocyclophosphamide in postimplantation rat embryos.
    Little SA; Mirkes PE
    Teratology; 1990 Feb; 41(2):223-31. PubMed ID: 2321166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of an in vitro teratology system using chiral substances: stereoselective teratogenicity of 4-yn-valproic acid in cultured mouse embryos.
    Andrews JE; Ebron-McCoy M; Bojic U; Nau H; Kavlock RJ
    Toxicol Appl Pharmacol; 1995 Jun; 132(2):310-6. PubMed ID: 7785058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.